Although increased ICAM-1 associated with early-stage AD has been reported in various studies including ours, the role of ICAM-1 does not seem to be a simple driver for neuroinflammation, but seems to be specific the pathophysiomechanism of AD. The gene discussed is ICAM1; the disease is Alzheimer disease.